Immune Activation Effects at Different Irradiated Sites and Optimal Timing of Radioimmunotherapy in Patients with Extensive-Stage Small Cell Lung Cancer: a Real-World Analysis
Abstract Background In view of the limited data on radiotherapy (RT) combined with immunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC), this study aimed to identify the immune activation effect on different sites and the survival outcomes of radioimmunotherapy at differen...
Main Authors: | Min Wu, Shihao Wu, Yuetong Chen, Liangchao Sun, Jundong Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Biological Procedures Online |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12575-023-00217-y |
Similar Items
-
Antibody conjugate radioimmunotherapy of superficial bladder cancer
by: Alan Perkins, et al.
Published: (2002-09-01) -
RADIOIMMUNOTHERAPY IN THE TREATMENT OF MALIGNANCIES
by: V. I. Chernov, et al.
Published: (2016-07-01) -
Radioimmunotherapy: future prospects
from the perspective of brachytherapy
by: Maximilian Fleischmann, et al.
Published: (2021-08-01) -
Extensive Stage Small-Cell Lung Cancer with Cystic Brain Metastases: A Report of Two Cases
by: Cai F, et al.
Published: (2024-03-01) -
Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma
by: Hiroki Goto, et al.
Published: (2024-02-01)